Assenagon Asset Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-423,416
Closed -$5.77M 1541
2022
Q4
$5.77M Sell
423,416
-251,478
-37% -$3.5M 0.02% 511
2022
Q3
$9.35M Sell
674,894
-184,171
-21% -$2.73M 0.04% 353
2022
Q2
$12.3M Buy
859,065
+461,931
+116% +$8.02M 0.05% 322
2022
Q1
$8.97M Sell
397,134
-91,165
-19% -$1.77M 0.02% 397
2021
Q4
$9.17M Buy
488,299
+391,400
+404% +$10.4M 0.03% 349
2021
Q3
$3.18M Buy
+96,899
New +$3.61M 0.01% 556
2021
Q2
Sell
-64,443
Closed -$2.47M 1467
2021
Q1
$2.47M Buy
64,443
+16,894
+36% +$719K 0.01% 668
2020
Q4
$2.08M Buy
+47,549
New +$1.79M 0.01% 523
2020
Q3
Sell
-54,666
Closed -$1.73M 1416
2020
Q2
$1.73M Sell
54,666
-42,987
-44% -$1.61M 0.01% 644
2020
Q1
$3.44M Buy
+97,653
New +$4.12M 0.03% 263

Other funds holding CSII

Assenagon Asset Management's CSII Position: Q1 2023 in Review

Assenagon Asset Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 423,416 shares — an estimated $5.77M sold.

Assenagon Asset Management first reported a position in CSII in Q1 2020 and held it in 10 quarters. The position peaked at $12.3M in Q2 2022. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

  • Assenagon Asset Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 423,416 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $5.77M.
  • Assenagon Asset Management first reported a position in Cardiovascular Systems, Inc. in Q1 2020 and held it in 10 quarters.
  • Assenagon Asset Management's Cardiovascular Systems, Inc. position peaked at $12.3M in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Assenagon Asset Management's 13F filing for Q1 2023, filed 18 Apr 2023.